familymednews.com
For people diagnosed with advanced pancreatic cancer, the outlook is about as grim as it gets: the average patient won’t live longer than a year. But a new study involving a targeted drug therapy has demonstrated it may be possible to significantly slow its spread, with a third of patients receiving the medication still alive two years into a clinical […]
Continue reading »
Children with type 1 diabetes find it difficult to adhere to their drug routines during school holidays and weekends. Holiday distractions cause a 20 percent reduction in adherence to taking medications that assist managing their condition and other associated conditions, which may have serious consequences for their health. “The research, published in the journal Archives of Disease in Childhood, shows […]
Continue reading »
Electronic vapor product (EVP) usage among U.S. high school students is associated with a higher likelihood of engagement in nine out of 10 sexual risk behaviors, according to a new study which analyzed data from the 2017 National Youth Risk Behavior Survey. A related study found that adolescent EVP use is associated with a higher likelihood of engagement in several […]
Continue reading »
(HealthDay)—Long-term osteoporosis drug therapy (ODT) reduces fracture risk in women but may increase risk for rare adverse events, and research gaps surround use of long-term drug therapies for osteoporotic fracture prevention, according to a review and position paper published online April 23 in the Annals of Internal Medicine. Howard A. Fink, M.D., M.P.H., from the University of Minnesota in Minneapolis, […]
Continue reading »
About one in eight women in the United States will develop breast cancer in their lifetime. The vast majority of these cancers rely on the hormone estrogen to grow. Estrogen-receptor positive (ER+) breast cancer tumors are frequently treated with the drug tamoxifen, which blocks the hormone’s effect on the tumor. However, many tumors eventually become resistant to tamoxifen, allowing cancer […]
Continue reading »
A novel type of body awareness training helps women recover from drug addiction, according to new research from the University of Washington. People in the study made marked improvement, and many improvements lasted for a year. It’s the first time the mindfulness approach has been studied in a large randomized trial as an adjunct treatment. The training helps people better […]
Continue reading »
Every person in the U.S. will experience, on average, two broken bones in their lifetime. It is expected that more than 6.3 million bones will be broken in the U.S. this year, according to the National Institutes of Health. Average recovery time for a young, healthy adult with a broken arm is six to eight weeks. Average recovery time for […]
Continue reading »
A new antibiotic developed by a Flinders University researcher is being heralded as a breakthrough in the war against a drug resistant superbug. Bacteria are winning the fight against antibiotics as they evolve to fight off traditional treatments, threatening decades of advancements in modern medicine, with predictions they will kill over 10 million people by 2050. The scientific development of […]
Continue reading »
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults. Apolipoprotein E (ApoE) is a protein that carries fatty substances […]
Continue reading »
Researchers have found that the anti-parasite drug benznidazole may improve the long-term prognoses of patients with chronic Chagas disease, according to a study published in PLOS Neglected Tropical Diseases, by Clareci Silva Cardoso at the Federal University of São João del-Rei, Divinópolis, Brazil, and colleagues from the SaMi-Trop study, a project funded by NIAID/NIH. Caused by exposure to the protozoa […]
Continue reading »